Guardant Health is a precision oncology company that specializes in transforming cancer care through innovative liquid biopsy technology. Their mission is to improve patient outcomes by providing non-invasive tests that enable early cancer detection, monitoring, and treatment decisions, thereby driving advancements in cancer management. Guardant Health’s flagship product, Guardant SHIELD, is designed for early colorectal cancer detection, while their comprehensive portfolio includes tests for various cancer types. The company emphasizes collaboration, accountability, integrity, and quality in all its endeavors, fostering a culture that prioritizes teamwork and innovation. With a commitment to enhancing oncology through advanced diagnostics, Guardant Health plays a crucial role in the evolution of personalized cancer care, partnering with healthcare providers and institutions to deliver impactful solutions.